Palo Alto Investors’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,003,875
| Closed | -$28.2M | – | 44 |
|
|
2020
Q3 | $28.2M | Buy |
3,003,875
+44,288
| +1% | +$421K | 1.55% | 15 |
|
|
2020
Q2 | $22.6M | Sell |
2,959,587
-43,161
| -1% | -$330K | 1.36% | 18 |
|
|
2020
Q1 | $18.6M | Sell |
3,002,748
-41,626
| -1% | -$367K | 1.55% | 16 |
|
|
2019
Q4 | $37M | Sell |
3,044,374
-34,500
| -1% | -$377K | 2.04% | 17 |
|
|
2019
Q3 | $35.6M | Sell |
3,078,874
-296,632
| -9% | -$3.12M | 2.37% | 16 |
|
|
2019
Q2 | $33.7M | Sell |
3,375,506
-45,800
| -1% | -$494K | 1.64% | 18 |
|
|
2019
Q1 | $44.1M | Buy |
3,421,306
+40,800
| +1% | +$608K | 1.84% | 18 |
|
|
2018
Q4 | $51.4M | Hold |
3,380,506
| – | – | 2.73% | 13 |
|
|
2018
Q3 | $67.6M | Buy |
3,380,506
+39,700
| +1% | +$904K | 2.73% | 15 |
|
|
2018
Q2 | $65.1M | Hold |
3,340,806
| – | – | 2.6% | 15 |
|
|
2018
Q1 | $67.3M | Sell |
3,340,806
-152,414
| -4% | -$2.58M | 2.88% | 12 |
|
|
2017
Q4 | $46.3M | Buy |
3,493,220
+51,987
| +2% | +$784K | 1.99% | 16 |
|
|
2017
Q3 | $63.5M | Buy |
3,441,233
+96,613
| +3% | +$1.8M | 2.67% | 12 |
|
|
2017
Q2 | $61.5M | Hold |
3,344,620
| – | – | 2.87% | 12 |
|
|
2017
Q1 | $75.4M | Hold |
3,344,620
| – | – | 3.56% | 11 |
|
|
2016
Q4 | $116M | Buy |
3,344,620
+17,900
| +0.5% | +$535K | 6.64% | 5 |
|
|
2016
Q3 | $81.5M | Buy |
3,326,720
+53,500
| +2% | +$1.34M | 4.74% | 5 |
|
|
2016
Q2 | $78.3M | Buy |
3,273,220
+367,026
| +13% | +$8.41M | 5.91% | 4 |
|
|
2016
Q1 | $68M | Buy |
2,906,194
+70,402
| +2% | +$1.67M | 5.28% | 5 |
|
|
2015
Q4 | $85.6M | Buy |
2,835,792
+58,400
| +2% | +$1.89M | 4.77% | 7 |
|
|
2015
Q3 | $110M | Buy |
2,777,392
+585,251
| +27% | +$36.3M | 5.31% | 6 |
|
|
2015
Q2 | $151M | Buy |
2,192,141
+5,100
| +0.2% | +$321K | 6.73% | 6 |
|
|
2015
Q1 | $120M | Buy |
2,187,041
+192,841
| +10% | +$9.19M | 5.91% | 6 |
|
|
2014
Q4 | $85M | Buy |
1,994,200
+379,664
| +24% | +$13.7M | 4.99% | 8 |
|
|
2014
Q3 | $51.5M | Hold |
1,614,536
| – | – | 3.85% | 9 |
|
|
2014
Q2 | $33.5M | Hold |
1,614,536
| – | – | 2.49% | 13 |
|
|
2014
Q1 | $31.2M | Sell |
1,614,536
-146,796
| -8% | -$3.12M | 2.58% | 13 |
|
|
2013
Q4 | $42.8M | Buy |
1,761,332
+45,955
| +3% | +$1.08M | 3.99% | 10 |
|
|
2013
Q3 | $36.8M | Buy |
1,715,377
+34,506
| +2% | +$815K | 3.86% | 12 |
|
|
2013
Q2 | $37.4M | Buy |
+1,680,871
| New | +$37M | 4.41% | 8 |
|
Palo Alto Investors's AMAG Position: Q4 2020 in Review
Palo Alto Investors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 3,003,875 shares — an estimated $28.2M sold.
Palo Alto Investors first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $151M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Palo Alto Investors reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Palo Alto Investors sold 3,003,875 AMAG Pharmaceuticals shares in Q4 2020, an estimated $28.2M.
- Palo Alto Investors first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Palo Alto Investors's AMAG Pharmaceuticals position peaked at $151M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Palo Alto Investors's 13F filing for Q4 2020, filed 16 Feb 2021.